Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

被引：0
|
作者：
Locke, Margaret [1 ,4 ]
Kohn, Nina [2 ]
Seetharamu, Nagashree [3 ]
机构：
[1] Zucker Sch Med Hofstra Northwell, Dept Internal Med, Manhasset, NY USA
[2] Northwell Hlth, Off Acad Affairs, Manhasset, NY USA
[3] Northwell Hlth, Monter Canc Ctr, Manhasset, NY USA
[4] 300 Community Dr, Manhasset, NY 11030 USA
来源：
CLINICAL OTOLARYNGOLOGY | 2023年 / 48卷 / 06期
关键词：
chemotoxicity; head and neck cancer; metastatic disease; unresectable head and neck cancer; CHEMOTHERAPY; RECURRENT;
D O I：
10.1111/coa.14091
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：915 / 919
页数：5
相关论文
共 50 条
  • [21] Weekly paclitaxel/carboplatin and radiotherapy in inoperable squamous cell carcinoma of head & neck and lung
    Schmidt, P
    Heck, HK
    Preiss, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 874 - 874
  • [22] Weekly paclitaxel, carboplatin and cetuximab (PCC) as first-line treatment of recurrent and/or metastatic head & neck squamous cell carcinoma (R/M-HNSCC) for patients ineligible to cisplatin based chemotherapy
    Carinato, H.
    Burgy, M.
    Fischbach, C.
    Kalish-Weindling, M.
    Pabst, L.
    Frasie, V.
    Thiery, A.
    Coliat, P.
    Demarchi, M. F.
    Petit, T.
    Borel, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S668 - S668
  • [23] Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Okamoto, Isaku
    Sato, Hiroki
    Ito, Tatsuya
    Miyake, Keitaro
    Tsukahara, Kiyoaki
    IN VIVO, 2021, 35 (02): : 1253 - 1259
  • [24] PHASE II STUDY EVALUATING THE ADDITION OF CETUXIMAB TO THE CONCURRENT DELIVERY OF WEEKLY CARBOPLATIN, PACLITAXEL, AND DAILY RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK
    Suntharalingam, Mohan
    Kwok, Young
    Goloubeva, Olga
    Parekh, Arti
    Taylor, Rodney
    Wolf, Jeffrey
    Zimrin, Ann
    Strome, Scott
    Ord, Robert
    Cullen, Kevin J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1845 - 1850
  • [25] A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck
    Conley, B
    Jacobs, M
    Suntharalingam, M
    Zacharski, D
    Ord, RA
    Gray, W
    Aisner, J
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S78 - S80
  • [26] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chauffert, Bruno
    Zhou, Yuedan
    Medjkoune, Liza
    Ouikene, Abdenour
    Galez, Agnes
    Belkhir, Farid
    Saint-Germain, Pierre
    Youssef, Ali
    Chehimi, Mohamad
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
  • [27] Evaluation of weekly paclitaxel, carboplatin, and cetuximab in head and neck cancer patients with incurable disease
    Narveson, Lisa
    Kathol, Emily
    Rockey, Michelle
    Henry, David
    Grauer, Dennis
    Neupane, Prakash
    MEDICAL ONCOLOGY, 2016, 33 (10)
  • [28] Evaluation of weekly paclitaxel, carboplatin, and cetuximab in head and neck cancer patients with incurable disease
    Lisa Narveson
    Emily Kathol
    Michelle Rockey
    David Henry
    Dennis Grauer
    Prakash Neupane
    Medical Oncology, 2016, 33
  • [29] Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease
    Narveson, L.
    Kathol, E.
    Rockey, M.
    Henry, D.
    Grauer, D.
    Neupane, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 933 - 934
  • [30] Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck
    Moosmann, P
    Egli, F
    Stahel, RA
    Jost, L
    ONKOLOGIE, 2003, 26 (06): : 568 - 572
12345